ORPHA — Orphazyme A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK36.97m
- DKK25.70m
Annual cashflow statement for Orphazyme A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -336 | -633 | -627 | -41.2 | -27 |
| Depreciation | |||||
| Non-Cash Items | 2.55 | 52.8 | 9.25 | -76.5 | 0 |
| Discontinued Operations | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.78 | 36.2 | -3.4 | -1.99 | 7.02 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -327 | -539 | -603 | -118 | -20 |
| Capital Expenditures | -3.29 | -5.1 | -0.994 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | 1.04 | 90.3 | -6.94 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -3.29 | -5.1 | 0.046 | 90.3 | -6.94 |
| Financing Cash Flow Items | — | -108 | 0 | -0.141 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 58.9 | 1,159 | -30.3 | -35.1 | -0.685 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -271 | 603 | -625 | -65.6 | -27.6 |